s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, November 23, 2020
Accession number
0001493152-20-022177
Documents
form8-k.htm
425
ex10-1.htm
EX-10.1
ex10-2.htm
EX-10.2
On sec.gov
Filing index
All files
Complete submission text
SGML header